Some years ago, we designed1a a stereoselective synthesis of (1RS)-cis-chrysanthemic acid 1a (R1, R2 ) Me)2 from dimethyldimedone 2a (R1, R2 ) Me) which uses cheap reagents compatible with industrial requirements. The key steps of this process are (i) the cyclopropanation of 2a, which produced the bicyclo[3.1.0]hexa-2,4-dione1a,3 3a, and (ii) the Grob fragmentation4 on the mesylate 5a derived from â-hydroxy ketone 4a, itself resulting from the mono-reduction of 3a. The stereochemical outcome of each individual step that is important for the success of the whole process is depicted in Scheme 1.1 Most of the reducing agents used, including sodium borohydride (methanol, -78 °C), efficiently achieved5 monoreduction of the bicyclic dione 3a but delivered, exclusively or mainly, the endo alcohol 4aendo. This alcohol, which results from the attack of the hydride from the least hindered exo face of 3a,1a,b is unsuitable, however, for the synthesis of 1a. This synthesis has been nevertheless successfully achieved from the exo stereoisomer 4aexo, readily available from the reduction of 3a1a,b with sodium borohydride-cerium trichloride (methanol, -78 °C, Luche’s reagent).6 This synthetic approach has been successfully extended to homologous derivatives of 1 bearing one methyl group and one hydrogen or even two hydrogens on the cyclopropane ring. This approach is unsuitable, however, for the synthesis (for example) of derivatives 1 bearing one or two hydrogens on the terminal sp2 carbon, due to competing metalation at the position R to the carbonyl group of 2 and 4 (R1 or/and R2 ) H).